Amgen AMGN Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 68.3%+5.3pp | 67.2%+5.7pp | 66.2%+5.7pp | 64.5%+1.2pp | 63%-3.4pp | |
| Operating margin | 28.4%+6.6pp | 24.7%+3.0pp | 24.1%+5.0pp | 23.5%+3.4pp | 21.8%-1.8pp | |
| Net margin | 21%+3.6pp | 21%+8.7pp | 19.5%+6.5pp | 19%+8.8pp | 17.4%+4.6pp | |
| EBITDA margin | 41.5%+3.4pp | 38.8%+0.3pp | 39.2%+3.0pp | 39.3%+2.9pp | 38.2%-0.9pp | |
| Free cash flow margin | 23.1%-8.9pp | 22%-9.1pp | 32.1%+12.8pp | 30.4%+12.7pp | 32%+7.9pp | |
| Returns | ||||||
| Return on equity | 101.3%-4.4pp | 106.1%+38.5pp | 81.7%+26.0pp | 99.1%+49.9pp | 105.7%+33.1pp | |
| Return on assets | 8.6%+2.1pp | 8.5%+4.1pp | 7.7%+3.1pp | 7.4%+3.9pp | 6.5%+2.4pp | |
| Return on invested capital | 14.1%+4.0pp | 12%+2.6pp | 11.3%+2.9pp | 11.1%+3.0pp | 10.1%+1.2pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Inventory turnover | 1.8×+0.2× | 1.8×+0.3× | 1.8×-0.3× | 1.7×0.0× | 1.6×+0.2× | |
| Liquidity | ||||||
| Current ratio | 1.3×+0.1× | 1.1×-0.1× | 1.3×0.0× | 1.3×0.0× | 1.2×-0.3× | |
| Quick ratio | 1×+0.1× | 0.9×-0.1× | 1×0.0× | 1×+0.1× | 0.9×-0.1× | |
| Cash ratio | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 6.2×-3.0× | 6.4×-4.0× | 5.7×-2.3× | 7.6×-3.0× | 9.2×-3.5× | |
| Debt-to-assets | 0.6×0.0× | 0.6×-0.1× | 0.6×-0.1× | 0.6×0.0× | 0.6×0.0× | |
| Net debt / EBITDA | 3.7×-0.7× | 3.8×-0.9× | 3.8×-1.3× | 4.1×-1.5× | 4.4×-1.1× | |
| Interest coverage | 3.9×+1.5× | 3.3×+1.0× | 3×+1.1× | 2.8×+0.9× | 2.4×+0.2× | |
| Per Share | ||||||
| Book value per share | $16.89+47.2% | $15.97+47.0% | $17.75+27.8% | $13.73+25.4% | $11.47+22.5% | |
| Valuation | ||||||
| Market capitalization | $189.67B+13.3% | $176.25B+25.8% | $151.93B-12.2% | $149.21B-11.0% | $167.37B+9.8% | |
| Enterprise value | $246.43B+9.9% | $231.08B+15.3% | $205.78B-11.7% | $204.87B-10.8% | $224.24B+3.9% | |
| Price / earnings | 24.3×-3.9× | 22.9×-11.4× | 21.7×-19.2× | 22.5×-31.0× | 28.2×-12.3× | |
| Price / sales | 5.1×+0.2× | 4.8×+0.6× | 4.2×-1.1× | 4.3×-1.1× | 4.9×-0.3× | |
| Price / book | 20.6×-6.3× | 20.4×-3.5× | 15.8×-7.2× | 20.1×-8.2× | 27×-3.4× | |
| EV / EBITDA | 15.9×-1.3× | 16.2×+0.6× | 14.6×-5.2× | 14.9×-5.5× | 17.2×-1.5× | |
| EV / sales | 6.6×+0.1× | 6.3×+0.3× | 5.7×-1.4× | 5.9×-1.6× | 6.6×-0.7× | |
| Free cash flow yield | 4.5%-2.0pp | 4.6%-2.8pp | 7.6%+4.0pp | 7.1%+3.8pp | 6.5%+1.9pp | |
| Earnings yield | 4.1%+0.6pp | 4.4%+1.5pp | 4.6%+2.2pp | 4.4%+2.6pp | 3.5%+1.1pp | |
| Dividend yield | 2.7%-0.2pp | 2.9%-0.5pp | 3.3%+0.6pp | 3.3%+0.5pp | 2.9%-0.1pp | |
| PEG ratio | 0.8×+0.3× | 0.3×— | 0.3×— | 0.2×— | 0.5×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Amgen's profit margins?
- Amgen (AMGN) runs a 68.3% gross margin and a 28.4% operating margin, with a 21.0% net margin.
- Where do Amgen's ratios come from?
- Every ratio is computed from Amgen's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
